What does PHARMAYOU WAREMME SAINT-ELOI do?

PHARMAYOU WAREMME SAINT-ELOI is a pharmacy in Waremme. Public Limited, started on 10 May 2000, 1 establishment.

What is the address of PHARMAYOU WAREMME SAINT-ELOI?

The registered office of PHARMAYOU WAREMME SAINT-ELOI is located at Rue Saint-Eloi 205, 4300 Waremme.

Is PHARMAYOU WAREMME SAINT-ELOI still active?

Yes. According to the CBE (16 September 2026) PHARMAYOU WAREMME SAINT-ELOI is active, legal situation “Normale toestand”, started on 10 May 2000.

Is PHARMAYOU WAREMME SAINT-ELOI registered on Peppol?

Yes, PHARMAYOU WAREMME SAINT-ELOI is registered on the Peppol network with ID 0208:0471848382.

What is the enterprise number of PHARMAYOU WAREMME SAINT-ELOI?

The enterprise number of PHARMAYOU WAREMME SAINT-ELOI is BE0471848382.

When was PHARMAYOU WAREMME SAINT-ELOI founded?

PHARMAYOU WAREMME SAINT-ELOI was founded on 10 May 2000.

Who are the directors of PHARMAYOU WAREMME SAINT-ELOI?

According to the 2025 annual accounts, the directors of PHARMAYOU WAREMME SAINT-ELOI are: MOES SA, Corinne BLISTIN, Francis MOES.

Is PHARMAYOU WAREMME SAINT-ELOI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 May 2000; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did PHARMAYOU WAREMME SAINT-ELOI make in 2025?

PHARMAYOU WAREMME SAINT-ELOI posted a profit after taxes of € 227,223 in financial year 2025.

What is the revenue of PHARMAYOU WAREMME SAINT-ELOI?

As a small company, PHARMAYOU WAREMME SAINT-ELOI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 860,222.

How much does an employee at PHARMAYOU WAREMME SAINT-ELOI earn?

The average wage cost per full-time employee at PHARMAYOU WAREMME SAINT-ELOI was € 146,400 in 2025: staff costs of € 424,489 for 2.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMAYOU WAREMME SAINT-ELOI have?

According to the 2025 annual accounts, PHARMAYOU WAREMME SAINT-ELOI has 2.9 full-time equivalents (FTE).

PHARMAYOU WAREMME SAINT-ELOI (Public Limited) - Waremme

Dossier PHARMAYOU WAREMME SAINT-ELOI, printed on 16 September 2026 from databakkes.be/en/0471848382/pharmayou-waremme-saint-eloi. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 5.2 to 2.9.

Financials

Financial year 2025

PHARMAYOU WAREMME SAINT-ELOI from Waremme, company number BE0471848382, closed financial year 2025 with a result of € 227,223 after tax. For that financial year PHARMAYOU WAREMME SAINT-ELOI recorded a gross margin of € 860,222 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 283,137 to € 227,223. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1.4 million

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 227,223

▼ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 211,532

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.3 million.

People and assets in 2025

Full-time equivalents

2.9

▼ 1.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 424,489

▲ 14% vs 2024

€ 146,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,401

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 184,432

▼ 24% vs 2024

€ 57,611 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 205,158

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 27,900

▼ 66% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 368,524 Gross margin 2022: € 368,524 First fiscal year in the series	€ 659,469 Gross margin 2023: € 659,469 ▲ 79% vs 2022 (€ 368,524) Favourable step	€ 862,969 Gross margin 2024: € 862,969 ▲ 31% vs 2023 (€ 659,469) Favourable step	€ 860,222 Gross margin 2025: € 860,222 Unchanged (€ 862,969) Unfavourable step
Profit after taxes	€ 134,828 Profit after taxes 2022: € 134,828 First fiscal year in the series	€ 199,458 Profit after taxes 2023: € 199,458 ▲ 48% vs 2022 (€ 134,828) Favourable step	€ 283,137 Profit after taxes 2024: € 283,137 ▲ 42% vs 2023 (€ 199,458) Favourable step	€ 227,223 Profit after taxes 2025: € 227,223 ▼ 20% vs 2024 (€ 283,137) Unfavourable step	▼ 20%
Equity	€ 681,133 Equity 2022: € 681,133 First fiscal year in the series	€ 880,591 Equity 2023: € 880,591 ▲ 29% vs 2022 (€ 681,133) Favourable step	€ 1,163,728 Equity 2024: € 1,163,728 ▲ 32% vs 2023 (€ 880,591) Favourable step	€ 1,390,951 Equity 2025: € 1,390,951 ▲ 20% vs 2024 (€ 1,163,728) Favourable step	▲ 20%
Total debts	€ 853,659 Total debts 2022: € 853,659 First fiscal year in the series	€ 784,682 Total debts 2023: € 784,682 ▼ 8% vs 2022 (€ 853,659) Favourable step	€ 777,113 Total debts 2024: € 777,113 ▼ 1% vs 2023 (€ 784,682) Favourable step	€ 499,068 Total debts 2025: € 499,068 ▼ 36% vs 2024 (€ 777,113) Favourable step	▼ 36%
Cash	€ 196,941 Cash 2022: € 196,941 First fiscal year in the series	€ 318,224 Cash 2023: € 318,224 ▲ 62% vs 2022 (€ 196,941) Favourable step	€ 343,494 Cash 2024: € 343,494 ▲ 8% vs 2023 (€ 318,224) Favourable step	€ 211,532 Cash 2025: € 211,532 ▼ 38% vs 2024 (€ 343,494) Unfavourable step	▼ 38%
Land & buildings	€ 469,156 Land & buildings 2022: € 469,156 First fiscal year in the series	€ 464,570 Land & buildings 2023: € 464,570 ▼ 1% vs 2022 (€ 469,156) Unchanged	€ 445,474 Land & buildings 2024: € 445,474 ▼ 4% vs 2023 (€ 464,570) Unchanged	€ 414,900 Land & buildings 2025: € 414,900 ▼ 7% vs 2024 (€ 445,474) Unchanged	▼ 7%
Retained profit	€ 619,633 Retained profit 2022: € 619,633 First fiscal year in the series	€ 819,091 Retained profit 2023: € 819,091 ▲ 32% vs 2022 (€ 619,633) Favourable step	€ 1,102,228 Retained profit 2024: € 1,102,228 ▲ 35% vs 2023 (€ 819,091) Favourable step	€ 1,329,451 Retained profit 2025: € 1,329,451 ▲ 21% vs 2024 (€ 1,102,228) Favourable step	▲ 21%
Bank debt	€ 353,828 Bank debt 2022: € 353,828 First fiscal year in the series	€ 297,926 Bank debt 2023: € 297,926 ▼ 16% vs 2022 (€ 353,828) Favourable step	€ 241,468 Bank debt 2024: € 241,468 ▼ 19% vs 2023 (€ 297,926) Favourable step	€ 184,432 Bank debt 2025: € 184,432 ▼ 24% vs 2024 (€ 241,468) Favourable step	▼ 24%
Balance sheet total	€ 1,534,792 Balance sheet total 2022: € 1,534,792 First fiscal year in the series	€ 1,665,273 Balance sheet total 2023: € 1,665,273 ▲ 9% vs 2022 (€ 1,534,792) Unchanged	€ 1,940,841 Balance sheet total 2024: € 1,940,841 ▲ 17% vs 2023 (€ 1,665,273) Unchanged	€ 1,890,019 Balance sheet total 2025: € 1,890,019 ▼ 3% vs 2024 (€ 1,940,841) Unchanged	▼ 3%
Employees (FTE)	2.8 Employees (FTE) 2022: 2.8 First fiscal year in the series	5.2 Employees (FTE) 2023: 5.2 ▲ 2.4 vs 2022 (2.8) Unchanged	4.2 Employees (FTE) 2024: 4.2 ▼ 1 vs 2023 (5.2) Unchanged	2.9 Employees (FTE) 2025: 2.9 ▼ 1.3 vs 2024 (4.2) Unchanged	▼ 1.3

Key figures of PHARMAYOU WAREMME SAINT-ELOI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAYOU WAREMME SAINT-ELOI?

What happened at PHARMAYOU WAREMME SAINT-ELOI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 MOES SA stepped down as director. NBB
2029 Corinne BLISTIN stepped down as director. NBB
2029 Francis MOES stepped down as director. NBB
Aug 31, 2026 New annual accounts for financial year 2025: profit of € 227,223 (▼ 20% vs 2024). filed late Source: NBB ↗
2023 MOES SA became a director. NBB
2023 Corinne BLISTIN became a director. NBB
2023 Francis MOES became a director. NBB
Jun 27, 2000 New establishment in Waremme. KBO

In short

From € 134,828 profit in 2022 to € 227,223 profit in 2025.

Paid € 263,017 in corporate taxes since 2022.

Best year ever: 2024, with € 283,137 profit.

On average € 296,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMAYOU WAREMME SAINT-ELOI? We notify you, reason included.

Follow PHARMAYOU WAREMME SAINT-ELOI

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MOES 99%

The stake of MOES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMAYOU WAREMME SAINT-ELOI

The shares are held by MOES (99%).

See the full network in the app

Directors

According to the 2025 annual accounts

MOES SA

Managing director · represented by Corinne BLISTIN

Also active at: PHARMAYOU GLONS, Pharmacie d'Oupeye - Bernard, PHARMAYOU WANZE

since 2023 · until 2029

Corinne BLISTIN

Director

Also active at: PHARMAYOU GLONS, Pharmacie d'Oupeye - Bernard, PHARMAYOU WANZE, MOES, Pharmayou Tongeren, ARTHIRO, PHARMAYOU WAREMME GARE, DE PAUW H. MANAGEMENT

since 2023 · until 2029

Francis MOES

Director

Also active at: MAC, PHARMAYOU WANZE, MOES, Pharmayou Tongeren, ARTHIRO, PHARMAYOU WAREMME GARE, DE PAUW H. MANAGEMENT

since 2023 · until 2029

Shareholders

MOES

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Saint-Eloi 205

4300 Waremme

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PHARMAYOU SERVICES

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.848.382

VAT number

BE 0471.848.382

Registered office

Rue Saint-Eloi 205, 4300 Waremme

Names & denominations

PHARMAYOU WAREMME SAINT-ELOI

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

10 May 2000

Peppol

Active · Active since 19 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMAYOU WAREMME SAINT-ELOI

Warning lights

Financials

What happened to PHARMAYOU WAREMME SAINT-ELOI?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions